Justin Chan

AMMI Canada Practice Point: Treatments for adults with COVID-19 in 2021-2022.

J. Grant, Justin Chan, S. Lother, Lisa P. Barrett +5 more

2022Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada1 citations Open access

Semantic Scholar

Justin Chan

Most-cited papers

Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment

Jamestown Canyon virus in Massachusetts: clinical case series and vector screening

Outcomes of Hepatitis C Virus Treatment in the New York City Jail Population: Successes and Challenges Facing Scale up of Care

COVID-19 in the New York City Jail System: Epidemiology and Health Care Response, March–April 2020

The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014–2017

Patterns of practice and barriers to care for hepatitis C in the direct-acting antiviral (DAA) era: A national survey of Canadian infectious diseases physicians.

Perspectives on HCV: Current Therapeutic Regimens and Drug–Drug Interactions

The Role of a Tertiary Level Safety Net Hospital in New York City's 2022 Mpox Outbreak

Critical Elements of an Mpox Vaccination Model at the Largest Public Health Hospital System in the United States

Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention

Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public–private hospital partnership during the 2022 NYC mpox outbreak

Implementation and early outcomes of a telehealth visit model to deliver tecovirimat for mpox infection in New York City

AMMI Canada Practice Point: Treatments for adults with COVID-19 in 2021-2022.

Epidemiology of Biopsy Proven Glomerular Disorders and Effect of Severe Cyclone on Its Incidence in Central Queensland Region of Australia

Direct-Acting Antiviral (DAA) Therapy for Chronic Hepatitis C Virus (HCV) Infection Leads to Regression of Liver Fibrosis, Assessed by Serial Transient Elastography (Fibroscan)